William E. Schwarzmann
University of Pittsburgh
4 Papers
William E. Schwarzmann is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Vaccination & Influenza vaccine. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study.
Matthew K Hensley,William Bain,William Bain,Jana L. Jacobs,Sham Nambulli,Urvi M. Parikh,Anthony R. Cillo,Brittany Staines,Amy Heaps,Michele D. Sobolewski,Linda J. Rennick,Bernard J.C. Macatangay,Cynthia Klamar-Blain,Georgios D Kitsios,Barbara Methé,Ashwin Somasundaram,Tullia C. Bruno,Carly Cardello,Feng Shan,Creg J. Workman,Prabir Ray,Anuradha Ray,Janet S. Lee,Rahil Sethi,William E. Schwarzmann,Mark S. Ladinsky,Pamela J. Bjorkman,Dario A. A. Vignali,W. Paul Duprex,Mounzer Agha,John W. Mellors,Kevin D. McCormick,Alison Morris,Ghady Haidar +33 more
TL;DR: In this article, a chimeric antigen receptor-modified T-cell therapy recipient developed severe coronavirus disease 2019, intractable RNAemia, and viral replication lasting >2 months.
Differential gene expression in peripheral blood mononuclear cells from children immunized with inactivated influenza vaccine.
John F. Alcorn,Raghunandan Avula,Anish Chakka,William E. Schwarzmann,Mary Patricia Nowalk,Chyongchiou Jeng Lin,Marianna A. Ortiz,William Horne,Uma R. Chandran,Jennifer P. Nagg,Richard K. Zimmerman,Kelly Stefano Cole,Krissy K. Moehling,Judith M. Martin +13 more
TL;DR: Insight is provided into the expected molecular pathways to be temporally altered by influenza vaccination in children by identifying postvaccination transcriptomic changes in peripheral blood mononuclear cells from children.
22
HIV-1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial.
Urvi M. Parikh,Kerri J. Penrose,Amy Heaps,Elias K. Halvas,B Jay Goetz,Kelley C. Gordon,Russell L. Hardesty,Rahil Sethi,William E. Schwarzmann,Daniel W. Szydlo,Marla Husnik,Uma R. Chandran,Thesla Palanee-Phillips,Jared M. Baeten,John W. Mellors,Mtn Study Team +15 more
TL;DR: The MTN-020/ASPIRE study as mentioned in this paper was a placebo-controlled, Phase III safety and effectiveness study of DPV ring for HIV-1 prevention conducted at 15 sites in South Africa, Zimbabwe, Malawi and Uganda between 2012 and 2015.
The impact of physical frailty on the response to inactivated influenza vaccine in older adults.
Krissy K. Moehling,Bo Zhai,William E. Schwarzmann,Uma R. Chandran,Marianna A. Ortiz,Mary Patricia Nowalk,David A. Nace,Chyongchiou J. Lin,Chyongchiou J. Lin,Michael Susick,Min Z. Levine,John F. Alcorn,Richard K. Zimmerman +12 more
- 09 Dec 2020
TL;DR: Reduced effectiveness of influenza vaccine among older, frail individuals may be attributed to immunosenescence-related changes in PBMCs that are not reflected in antibody levels.